Microbix Biosystems Inc (TSE:MBX) Director Martin Marino bought 40,000 shares of Microbix Biosystems stock in a transaction on Tuesday, March 20th. The shares were acquired at an average cost of C$0.29 per share, for a total transaction of C$11,600.00.
MBX stock remained flat at $C$0.28 on Friday. The company had a trading volume of 30,700 shares, compared to its average volume of 44,337. Microbix Biosystems Inc has a twelve month low of C$0.22 and a twelve month high of C$0.40. The stock has a market capitalization of $27.10, a P/E ratio of -28.00 and a beta of -1.95.
Microbix Biosystems (TSE:MBX) last posted its earnings results on Thursday, December 21st. The company reported C($0.01) earnings per share for the quarter. Microbix Biosystems had a negative return on equity of 2.25% and a negative net margin of 3.26%. The business had revenue of C$2.81 million for the quarter.
About Microbix Biosystems
Microbix Biosystems Inc is a life science company and manufacturer of viral and bacterial antigens and reagents for the diagnostics industry. The Company develops biological products and technologies. The Company operates in two segments: the development, manufacturing and distribution of cell-based products and technology, and the provision of facility, technical and production personnel for contract research and development.
Receive News & Ratings for Microbix Biosystems Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Microbix Biosystems and related companies with MarketBeat.com's FREE daily email newsletter.